Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Natures Sunshine ProductsNATR | Open-market sale | 06/12 | 06/15 | 2,000 sh2 trades | $20.68avg. | $41,363.92 | −3.9% | |
Bryant J. YatesEVP & President, Europe | Natures Sunshine ProductsNATR | Open-market sale | 06/05 | 06/11 | 11,968 sh | $19.90 | $238,163.2 | −13.4% |
Daniel C. NormanEVP & President, Asia | Natures Sunshine ProductsNATR | Open-market sale | 06/01 | 06/03 | 9,713 sh | $20.64 | $200,476.32 | −17.0% |
Nathan G. BrowerEVP, General Counsel | Natures Sunshine ProductsNATR | Open-market sale | 05/21 | 05/22 | 12,015 sh | $21.84 | $262,407.6 | −21.7% |
Bryant J. YatesEVP & President, Europe | Natures Sunshine ProductsNATR | Open-market sale | 03/13 | 03/17 | 19,516 sh | $24.35 | $475,214.6 | −18.6% |
Daniel C. NormanEVP & President, Asia | Natures Sunshine ProductsNATR | Open-market sale | 03/13 | 03/17 | 15,383 sh | $24.52 | $377,191.16 | −21.6% |
Jonathan David LanoySVP, Chief Accounting Officer | Natures Sunshine ProductsNATR | Open-market sale | 03/13 | 03/16 | 4,000 sh | $24.70 | $98,800 | −7.9% |
Bryant J. YatesEVP & President, Europe | Natures Sunshine ProductsNATR | Open-market sale | 25/12/12 | 25/12/16 | 1,700 sh | $22.29 | $37,893 | −1.7% |
Jonathan David LanoySVP, Chief Accounting Officer | Natures Sunshine ProductsNATR | Open-market sale | 25/11/18 | 25/11/19 | 5,000 sh | $20.45 | $102,250 | −9.8% |
Daniel C. NormanEVP & President, Asia | Natures Sunshine ProductsNATR | Open-market sale | 25/11/12 | 25/11/19 | 8,884 sh | $20.46 | $181,766.64 | −11.8% |
Nathan G. BrowerEVP, General Counsel | Natures Sunshine ProductsNATR | Open-market sale | 25/11/14 | 25/11/18 | 3,800 sh | $20.81 | $79,078 | −7.5% |
Natures Sunshine ProductsNATR | Open-market sale | 25/08/26–25/08/29 | 25/09/04 | 9,672 sh2 trades | $16.74avg. | $161,919.12 | −9.0% | |
Nathan G. BrowerEVP, General Counsel | Natures Sunshine ProductsNATR | Open-market sale | 25/08/13 | 25/08/15 | 9,996 sh | $16.54 | $165,333.84 | −17.2% |
Jonathan David LanoySVP, Chief Accounting Officer | Natures Sunshine ProductsNATR | Open-market sale | 25/08/13 | 25/08/15 | 5,000 sh | $16.51 | $82,550 | −9.1% |
Shanghai Fosun Pharmaceutical10% Owner | Natures Sunshine ProductsNATR | Open-market sale | 25/06/27 | 25/06/27 | 2,854,607 sh | $11.46 | $32,713,796.22 | −100.0% |
Fosun Pharma USA10% Owner | Natures Sunshine ProductsNATR | Open-market sale | 25/06/27 | 25/06/27 | 2,854,607 sh | $11.46 | $32,713,796.22 | −100.0% |
Shanghai Fosun Pharmaceutical10% Owner | Natures Sunshine ProductsNATR | Open-market sale | 24/10/15 | 24/10/17 | 2,300 sh | $13.02 | $29,946 | −3.5% |
Natures Sunshine ProductsNATR | Open-market sale | 24/10/01–24/10/14 | 24/10/15 | 10,895 sh6 trades | $13.33avg. | $145,188.82 | −14.1% | |
Bryant J. YatesEVP & President, Europe | Natures Sunshine ProductsNATR | Open-market sale | 24/06/06 | 24/06/24 | 3,068 sh | $15.30 | $46,940.4 | −3.0% |
Natures Sunshine ProductsNATR | Open-market sale | 23/11/29–23/11/30 | 23/12/01 | 15,000 sh2 trades | $17.13avg. | $256,960 | −21.5% |